TY - CHAP
T1 - Par-1, -4, and the mTOR pathway following Germinal Matrix Hemorrhage
AU - Lekic, Tim
AU - Krafft, Paul R.
AU - Klebe, Damon
AU - Flores, Jerry
AU - Rolland, William B.
AU - Tang, Jiping
AU - Zhang, John H.
N1 - Funding Information:
This study was partially supported by the National Institutes of Health grant RO1 NS078755 (Dr. Zhang).
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Germinal matrix hemorrhage (GMH) is the most common cause of neurological complications of prematurity and has lasting implications. PAR-1 and PAR-4 receptors are involved with upstream signaling pathways following brain hemorrhage in adult models of stroke, of which the mammalian target of rapamycin (mTOR) is a potential downstream mediator. Therefore, we hypothesized a role for PAR-1, -4/ mTOR signaling following GMH brain injury. Postnatal day 7 Sprague-Dawley rats were subjected to GMH through stereotactic infusion of collagenase into the right ganglionic eminence. Rodents were euthanized at 72 h (short term), or 4 weeks (long term). Short-term mTOR expression was evaluated by Western blot in the context of PAR-1 (SCH-79797) and PAR-4 (P4pal10) inhibition. Pups in the long-term group were administered the selective mTOR inhibitor (rapamycin) with neurobehavioral and brain pathological examinations performed at 4 weeks. Pharmacological PAR-1, -4 antagonism normalized the increased mTOR expression following GMH. Early inhibition of mTOR by rapamycin improved long-term outcomes in rats. Mammalian-TOR signaling plays an important role in brain injury following neonatal GMH, possibly involving upstream PAR-1, -4 mechanisms.
AB - Germinal matrix hemorrhage (GMH) is the most common cause of neurological complications of prematurity and has lasting implications. PAR-1 and PAR-4 receptors are involved with upstream signaling pathways following brain hemorrhage in adult models of stroke, of which the mammalian target of rapamycin (mTOR) is a potential downstream mediator. Therefore, we hypothesized a role for PAR-1, -4/ mTOR signaling following GMH brain injury. Postnatal day 7 Sprague-Dawley rats were subjected to GMH through stereotactic infusion of collagenase into the right ganglionic eminence. Rodents were euthanized at 72 h (short term), or 4 weeks (long term). Short-term mTOR expression was evaluated by Western blot in the context of PAR-1 (SCH-79797) and PAR-4 (P4pal10) inhibition. Pups in the long-term group were administered the selective mTOR inhibitor (rapamycin) with neurobehavioral and brain pathological examinations performed at 4 weeks. Pharmacological PAR-1, -4 antagonism normalized the increased mTOR expression following GMH. Early inhibition of mTOR by rapamycin improved long-term outcomes in rats. Mammalian-TOR signaling plays an important role in brain injury following neonatal GMH, possibly involving upstream PAR-1, -4 mechanisms.
KW - Animals, Newborn
KW - Pyrroles/pharmacology
KW - Rats
KW - Quinazolines/pharmacology
KW - Thrombin/metabolism
KW - Rats, Sprague-Dawley
KW - Receptors, Thrombin/antagonists & inhibitors
KW - Signal Transduction/drug effects
KW - Blotting, Western
KW - Receptor, PAR-1/antagonists & inhibitors
KW - Sirolimus/pharmacology
KW - Brain/drug effects
KW - TOR Serine-Threonine Kinases/antagonists & inhibitors
KW - Animals
KW - Behavior, Animal/drug effects
KW - Oligopeptides/pharmacology
KW - Immunosuppressive Agents/pharmacology
KW - Intracranial Hemorrhages/metabolism
UR - http://www.scopus.com/inward/record.url?scp=84944474713&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84944474713&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/c05b7960-199f-30ac-9a20-e57fb2f1952a/
U2 - 10.1007/978-3-319-18497-5_38
DO - 10.1007/978-3-319-18497-5_38
M3 - Chapter (peer-reviewed)
C2 - 26463951
SN - 978-3-319-18496-8
SN - 978-3-319-36532-9
VL - 121
T3 - Acta Neurochirurgica, Supplementum
SP - 213
EP - 216
BT - Brain Edema XVI
PB - Springer Cham
ER -